Conjugation and Labeling Services market 2023 – Industry Growth by 2035

The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers

Roots Analysis is pleased to announce the publication of its recent study, titled, “Conjugation and Labeling Services Market, 2023-2035”

The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes

 An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
 A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels.
 A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services.
 A company competitiveness analysis of conjugation and labeling service providers.
 Elaborate profiles of prominent players offering conjugation and labeling services (shortlisted based on a proprietary criterion).
 A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.
 A detailed analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Type of Molecule
 Proteins
 Peptides
 Small Molecules
 Antibodies
 Other Molecules

 Type of Molecular Conjugate / Label
 Polymers
 Haptens
 Enzymes
 Fluorescent Tags
 Bead Coupling / Particle Conjugates
 Quantum Dots
 Isotopes
 Other Molecular Conjugates / Labels

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Key companies covered in the report
 AltaBioscience
 Bachem
 Bio-Synthesis
 Cayman Chemical
 CliniSciences
 Eurogentec
 GBI
 Mimotopes
 Peptide Institute
 piCHEM

For additional details, please visit https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html

News article
Biopharmaceutical Filtration Market

Learn from experts: do you know about these emerging industry trends?
T-cell Immunotherapies: The Future of Modern Cancer Treatments
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Long Acting Drugs market Research Report by 2022, Forecast till 2035

The conventional treatment options available for several diseases are known to be associated with several challenges, such as patient non-compliance, non-adherence to medication and multiple dosing regimen.

In order to circumvent the abovementioned challenges, the demand for long-acting drugs is increasing. The development and manufacturing of these novel pharmacological modalities require advanced long-acting drug delivery technologies and dedicated expertise available with service providers.

The financial opportunity within the long acting drug delivery technologies and services market has been analyzed across the following segments:
 Principle
 Manipulation of drug release from delivery systems
 Manipulation of in vivo clearance

 Strategy
 Chemical Modification
 Micro-encapsulation
 Long-Acting Hydrogels
 Long-Acting Implants
 Long-Acting Microneedles
 Multivesicular Liposomes
 Nanocrystal Suspensions
 Protein Fusion

 Compatible Dosage Form
 Injectables
 Implantables
 Oral Dosage Forms
 Topical / Transdermal Dosage Forms
 Vaginal Dosage Forms
 Other Dosage Forms

 Type of Molecules Delivered
 Small Molecules
 Biologics
 Other Molecules

 Type of Material Used
 Polymer based
 Non-polymer based

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa


The Long-Acting Drug Delivery Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 Adare Pharma Solutions
 AMW
 Bostal Drug Delivery
 Creative Biolabs
 ForDoz Pharma
 Innocore Pharmaceuticals
 Integral BioSystems
 LATITUDE Pharmaceuticals
 Navin Saxena Research and Technology Centre (NSRT)
 Samyang Biopharm

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Technology Landscape

5. Service Providers Landscape

6. Technology Competitiveness Analysis

7. Company Competitiveness Analysis

8. Company Profiles

9. Partnerships and Collaborations

10. Publication Analysis

11. Patent Analysis

12. Grant Analysis

13. Market Forecast and Opportunity Analysis

14. Conclusion

15. Interview Transcripts

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html

You may also be interested in the following titles:
Conjugation and Labeling Services Market

Bispecific Antibodies Market
4D Bioprinting Market

Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Fill Finish Biopharmaceuticals market 2022 – Industry Growth by 2035

Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.

This evident surge in the demand for biologics fill finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.

The financial opportunity within the biologics fill / finish services market has been analysed across the following segments:

 Type of Packaging Container
 Ampoules
 Cartridges
 Syringes
 Vials

 Type of Biologic
 Antibodies
 Cell Therapies
 Gene Therapies
 Oligonucleotides
 Proteins / Peptides
 Vaccines
 Others

 Therapeutic Area
 Oncological Disorders
 Autoimmune Disorders
 Infectious Diseases
 Cardiovascular Disorders
 Other Disorders

 Scale of Operation
 Preclinical / Clinical
 Commercial

 Company Size
 Large
 Mid-sized
 Small

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
 AbbVie Contract Manufacturing
 Asymchem
 BioReliance
 Boehringer Ingelheim BioXcellence
 Catalent Biologics
 Charles River Laboratories
 Fareva
 Fresenius Kabi
 Glaxo SmithKline
 Hetero Drugs
 Intas Pharmaceuticals
 Lonza
 Patheon
 Pierre Fabre
 Recipharm
 Samsun Biologics
 Syngene
 Takara Bio
 Wacker Biotech
 WuXi AppTec
 WuXi Biologics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Biologics Fill / Finish Service Providers: Market Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America

7. Biologics Fill / Finish Service Providers in Europe

8. Biologics Fill / Finish Service Providers in Asia-Pacific

9. Recent Partnerships

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish

14. Regional Capability Assessment

15. Market Sizing and Opportunity Analysis

16. Future Growth Opportunities

17. Case Study: Robotic Systems in Fill / Finish Operations

18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish

19. Concluding Remarks

20. Executive Insights

21. Appendix 1: Tabulated Data

22. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html

You may also be interested in the following titles:
Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market
Modular facility manufacturers market

Cell therapy manufacturing market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#biologics #fillfinish #fillfinishservices #MarketResearch #MarketInsights

Lab Automation market Analysis and Trends by 2022-2035

The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.
 A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength.
 Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
 A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
 An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
 A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s).
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Stage of Automation
 Pre-Analytical Stage
 Analytical Stage
 Post-Analytical Stage
 Total Lab Automation
 Type of Instrument
 Automated Liquid Handling Systems
 Automated Microplate Readers
 Automated Sampling Systems
 Analyzers
 Automated Storage and Retrieval Systems (ASRS)
 Other Instruments
 End-User
 Pharmaceutical and Biotechnology Companies
 Research and Diagnostic Laboratories
 Other End-Users
 Key Geographical Region
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Key companies covered in the report
 Abbott
 Anton Paar
 BD
 Beckman Coulter
 ERWEKA
 Leuze
 Ortho Clinical Diagnostics
 Pall Corporation
 PerkinElmer
 Roche Diagnostics
 Siemens Healthineers
 SYSTAG

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/lab-automation-market.html

You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market

Global Antibiotics Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#Labautomation #Laboratoryautomation #LaboratoryautomationSystem #MarketResearch #MarketInsights

Organ on a Chip market Share, Growth Analysis by 2035

With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry.

Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.

By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:
 Type of Product
 Organ(s) based
 Disease(s) based

 Type of Application Area
 Drug Discovery and Toxicity Testing
 Cancer Research
 Tissue Engineering and Regenerative Medicine
 Stem Cell Research

 Purpose
 Research Use
 Therapy Development

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)

The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:
 BEOnChip
 Dynamic42
 Emulate
 MIMETAS
 SynVivo
 TissUse
 uFluidix

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

1. Organ-on-Chip: Market Landscape

2. Organ-on-Chip Developers: Company Profiles

3. Patent Analysis

4. Brand Positioning Matrix

5. Academic Grants Analysis

6. Partnerships and Collaborations

7. Funding and Investment Analysis

8. Case Study: Scaffold-Free 3D Cell Culture Systems

9. Organ-on-Chip: Market Forecast and Opportunity Analysis

10. Conclusion

14. Executive Insights

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

You may also be interested in the following titles:
Blockchain Technology in Healthcare Market

Long-Acting Drug Delivery Technologies and Services Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#microfluidics #microfluidicchips #microphysiologicalsystems #MarketResearch #MarketInsights